Copy Link Print Information

Blinatumomab

(Synonyms: bscCD19xCD3; AMG-103; MEDI-538; MT-103; BLINCYTO)
3 Cited Publications
Kundenbewertung

Based on 3 publication(s) in Google Scholar

Blinatumomab (Anatumomab) is a bispecific monoclonal antibody with two binding sites, one for CD3E on T cells and one for CD19 on B cells. Blinatumomab can be used in research for acute lymphoblastic leukemia.

Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.

  • Reinheit: 97.33%
  • CAS. Nr.: 853426-35-4
  • Molecular Weight:54.09 kDa
  • Speicherung:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Experimental Validation Results for Blinatumomab
  • Experimental Validation Results for Blinatumomab
  • Experimental Validation Results for Blinatumomab
  • Experimental Validation Results for Blinatumomab
  • Blinatumomab Chemical Structure
    Blinatumomab Chemical Structure
CAS. Nr.: 853426-35-4
Größe
Preis
Verfügbarkeit
Menge
Amount: USD 0.00
Please select quantity
or
or

* Bitte wählen Sie Menge, bevor Sie Artikel hinzufügen.

To place orders, for customer services and technical support, please contact: MedChemExpress USA

Tel: 609-228-6898 E-mail: [email protected] [email protected]

Data Download
Blinatumomab Product Recommendations:

To place orders, for customer services and technical support, please contact:

609-228-6898
[email protected] [email protected]
Finden Sie Ihren Händler vor Ort Your local distributor: Hycultec GmbHHycultec
  • Biologische Aktivität
  • Chemical Information
  • Reinheit & Dokumentation
  • Verweise
  • Help & FAQs
You May Still Need
Top Publications Citing

Use of MCE Products

Publications Citing Use of MedChemExpress (MCE) Blinatumomab

More
Customer Validation & Images
Others
  • Others
Keywords
100 mg

Angebot einholen Auf Lager

Please select quantity
Amount: USD 0.00
Sign in to MedChemExpress Einloggen
Registrieren
Sign in to MedChemExpress
Neuen Account Registrieren

At least 6 characters

Personalize your experience, you are currently not signed in. For a better experience, please create an online profile, you can:

Obtain points redemption prizes
Check out faster
Add multiple shipping locations
View orders
Assay Types
  • 1/16

    (scFv-kappa-heavy)-(scFv-heavy-kappa)

  • 1/16

    Loaded Blinatumomab on CM5 Chip, can bind CD19 Protein, Human (CHO, Fc, HY-P7333) with an affinity constant of 11.02E-9 M as determined in SPR assay.

  • 1/16

    Flow cytometric analysis of 1×106 Jurkat cells labelling CD3E (red) with Blinatumomab (HY-P9963). Cells were fixed with 4% paraformaldehyde and permeabilised with 90% methanol. Then stained with the primary antibody at 1/200 dilution for an hour at 4℃. Alexa Goat Anti-Human IgG H&L (AF488) (HY-P83776) was used as the secondary antibody at 1/1,000 dilution for 30 minutes at 4℃. Human IgG1 kappa Isotype Control (HY-P99001, blue) was used as the isotype control.

  • 1/16

    Blinatumomab purchased from MedChemExpress. Usage Cited in: Cell Rep Med. 2024 Jun 18;5(6):101590. [Abstract]

    Customer Validation
     Histogram of the percentage of conjugated cells when 2 × 105 Dye 670-stained NY-ESO-1157-165-primed HLA-A∗0201-Raji cells were cocultured 1 h with mixed 2 × 104 CFSE-stained 1G4-PD-1-Jurkat cells and 2 × 104 Dye 450-stained PD-1-Jurkat cells. The concentration of αPD-1-(iRGD)2 was 10 μg/mL, while Blinatumomab (1 μg/mL; 1 h) .

  • Blinatumomab Chemical Structure
    1/16
  • Blinatumomab
  • Loaded Blinatumomab on CM5 Chip, can bind CD19 Protein, Human (CHO, Fc, HY-P7333) with an affinity constant of 11.02E-9 M as determined in SPR assay.
  • Flow cytometric analysis of 1×106 Jurkat cells labelling CD3E (red) with Blinatumomab (HY-P9963). Cells were fixed with 4% paraformaldehyde and permeabilised with 90% methanol. Then stained with the primary antibody at 1/200 dilution for an hour at 4℃. Alexa Goat Anti-Human IgG H&L (AF488) (HY-P83776) was used as the secondary antibody at 1/1,000 dilution for 30 minutes at 4℃. Human IgG1 kappa Isotype Control (HY-P99001, blue) was used as the isotype control.
  • (scFv-kappa-heavy)-(scFv-heavy-kappa)